Search papers, labs, and topics across Lattice.
1
0
0
1
Only the ICI–sorafenib combination suppressed tumor growth, whereas both monotherapies showed limited antitumor activity, and findings support ICI–sorafenib combination therapy as a promising therapeutic strategy for TNBC.